HealthManagement, Volume 9 - Issue 3, 2009

Hologic has booked a third quarter 2009 net income of 41 million dollars, compared with 61 million dollars in the year-ago quarter. Included in third quarter fiscal 2009 results were charges of 48 million dollars attributable to the amortisation of intangibles relating to the Cytyc merger and the Third Wave acquisition and, in addition, a full quarter of costs and expenses from Third Wave.


Hologic said the charges related to the Cytyc merger were attributable to the amortisation of intangibles and a restructuring charge in connection with the resignation of the company's executive chairman in May 2008, but there were no expenses attributable to Third Wave in the third quarter of fiscal 2008.


Third quarter fiscal 2009 revenues totaled 403.1 million dollars, a 6.1 percent decrease when compared with revenues of 429.5 million dollars in the third quarter of fiscal 2008.

«« FDA Recall Penumbra Neuron 5F Select Catheter


MIR Congress: Last Call for Participants! »»